News

Notification of a Potential Data Security Incident

Dear Madam/Sir: The Southern Illinois University School of Medicine, (“SIU”) is providing notice pursuant to 815 ILCS 530/25 in connection with an incident that may have involved the personal information of certain Illinois residents. This notice will be supplemented, if necessary, with any new significant facts discovered subsequent to its submission. While SIU is notifying you of this incident, SIU does not waive any rights or defenses relating to the incident or this notice. NATURE OF THE INCIDENT AND CORRECTIVE ACTIONS TAKEN SIU recently discovered that an unknown, unauthorized third party
Trial
Internal Medicine

COSIRA-II: Efficacy of the COronary SInus Reducer in Patients with Refractory Angina II

Active recruiting
To demonstrate the safety and effectiveness of the Shockwave Reducer for treatment of patients with refractory angina pectoris treated with maximally tolerated guideline-directed medical therapy who demonstrate objective evidence of reversible myocardial ischemia in the distribution of the left coronary artery and who are deemed unsuitable for revascularization.
Contact: Madison Hollinshead 217-545-9738
Trial
Cardiology

Dal-GenE-2: A phase 3, double-blind, randomized placebo-controlled study to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in a genetically defined population with a recent Acute Coronary Syndrome (ACS)

Active recruiting
The primary objective of this trial is to evaluate the potential of dalcetrapib to reduce the occurrence of fatal and non-fatal myocardial infarction in subjects with a documented recent ACS and the AA genotype at variant rs1967309 in the ADCY9 gene.
Contact: Madison Hollinshead 217-545-9738
Trial
Cardiology

Dal-GenE-2: A phase 3, double-blind, randomized placebo-controlled study to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in a genetically defined population with a recent Acute Coronary Syndrome (ACS)

Active recruiting
The primary objective of this trial is to evaluate the potential of dalcetrapib to reduce the occurrence of fatal and non-fatal myocardial infarction in subjects with a documented recent ACS and the AA genotype at variant rs1967309 in the ADCY9 gene.
Contact: Madison Hollinshead 217-545-9738
Trial
Cardiology

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI DTU Trial

Active not recruiting
The purpose of this clinical trial is to demonstrate the safety and effectiveness of primary left ventricular (LV) unloading and a 30-minute delay-to-reperfusion versus current standard of care in reducing infarct size and heart failure-related clinical events in patients presenting with anterior ST-elevation myocardial infarction (STEMI).
Contact: Kathlena Mottershaw 217-545-7387
Trial
Cardiology

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI DTU Trial

Active not recruiting
The purpose of this clinical trial is to demonstrate the safety and effectiveness of primary left ventricular (LV) unloading and a 30-minute delay-to-reperfusion versus current standard of care in reducing infarct size and heart failure-related clinical events in patients presenting with anterior ST-elevation myocardial infarction (STEMI).
Contact: Kathlena Mottershaw 217-545-7387
General Results

About your appointment | Moy Outpatient Building

Preparing for your visit What to bring To help us provide the best care possible, please bring the following to your appointment: Photo ID and insurance card , including the name, phone number and address of your insurance provider. Illinois Department of Healthcare and Family Services (IDHFS) card , if applicable. List of medications , including prescription and over-the-counter drugs, with dosage and frequency. Referral paperwork , if your plan requires it. Copay or payment due at the time of service. Medical records , including immunization history, X-rays and lab results, if available
Events

Memory and Aging ECHO

The Memory and Aging ECHO is hosted by specialists from the Dale and Deborah Smith Center for Alzheimer’s Research and Treatment at SIU Medicine in Springfield, IL. The discussion will focus on key topics centering on memory and aging, providing valuable insight and conversation about how to best care for patients and caregivers.
Events

Memory and Aging ECHO

The Memory and Aging ECHO is hosted by specialists from the Dale and Deborah Smith Center for Alzheimer’s Research and Treatment at SIU Medicine in Springfield, IL. The discussion will focus on key topics centering on memory and aging, providing valuable insight and conversation about how to best care for patients and caregivers.
Events

Memory and Aging ECHO

The Memory and Aging ECHO is hosted by specialists from the Dale and Deborah Smith Center for Alzheimer’s Research and Treatment at SIU Medicine in Springfield, IL. The discussion will focus on key topics centering on memory and aging, providing valuable insight and conversation about how to best care for patients and caregivers.
Subscribe to Patient